In 2019, Federico Chinni became the CEO of UCB Italy, a biopharmaceutical company with a focus in the areas of immunology and neurology. At UCB, their central mission is to deliver value for people living with severe immunological and neurological diseases now and into the future. They have recognized that leveraging digital technology allows them to think outside the box and create transformative projects that meet patients where they are.